Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society-Reference-Cited by-同舟云学术

Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

Published:2022-11-01 Issue:1 Volume:29 Page:11-36
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Vukusic Sandra¹^ORCID,Carra-Dalliere Clarisse²^ORCID,Ciron Jonathan³^ORCID,Maillart Elisabeth⁴^ORCID,Michel Laure⁵,Leray Emmanuelle⁶,Guennoc Anne-Marie⁷,Bourre Bertrand⁸,Laplaud David⁹,Androdias Géraldine¹⁰,Bensa Caroline¹¹,Bigaut Kevin¹²^ORCID,Biotti Damien³^ORCID,Branger Pierre¹³,Casez Olivier¹⁴,Cohen Mikael¹⁵^ORCID,Daval Elodie¹⁶,Deschamps Romain¹¹,Donze Cécile¹⁷,Dubessy Anne-Laure¹⁸,Dulau Cécile¹⁹,Durand-Dubief Françoise²⁰,Guillaume Maxime⁸,Hebant Benjamin⁸,Kremer Laurent¹²,Kwiatkowski Arnaud²¹,Lannoy Julien²²,Maarouf Adil²³^ORCID,Manchon Eric²⁴,Mathey Guillaume²⁵,Moisset Xavier²⁶^ORCID,Montcuquet Alexis¹⁹,Pique Julie²⁷,Roux Thomas⁴^ORCID,Marignier Romain²⁸^ORCID,Lebrun-Frenay; Christine²⁹

Affiliation:

1. Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France/INSERM 1028 et CNRS UMR 5292, Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, Bron, France/Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France/Eugène Devic EDMUS Foundation against Multiple Sclerosis, State-approved Foundation, Bron, France

2. Neurology Department, Hôpital Gui de Chauliac, CHU de Montpellier, Montpellier, France

3. Centre Ressources et Compétences sclérose en plaques (CRC-SEP) et Service de Neurologie B4, Hôpital Pierre-Paul Riquet, CHU Toulouse Purpan, Toulouse, France INSERM UMR1291 – CNRS UMR5051, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse 3, Toulouse, France

4. Neurology Department, Pitié-Salpêtrière Hospital, CRC-SEP, Paris, France

5. Neurology Department, CIC_P1414 INSERM, Rennes University Hospital, Rennes, France

6. EHESP, CNRS, Inserm, Arènes – UMR 6051, RSMS (Recherche sur les Services et Management en Santé) – U 1309, Université de Rennes, Rennes, France

7. CRC SEP et Service de Neurologie, CHU Tours, Tours, France

8. Department of Neurology, CHU Rouen, Rouen, France

9. Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes Université and INSERM, Nantes, France/CIC INSERM 1413, CRC-SEP Pays de la Loire, CHU Nantes, Nantes, France

10. Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France/Clinique de la Sauvegarde, Ramsay Santé, Lyon, France

11. CRC-SEP, Neurology Department, Hôpital Fondation Adolphe de Rothschild, Paris, France

12. CRC-SEP, Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

13. Service de Neurologie, CHU de Caen Normandie, Caen, France

14. Pathologies Inflammatoires du Système Nerveux, Neurologie, CHU Grenoble Alpes, Grenoble, France/Translational Research in Autoimmunity and Inflammation Group (T-RAIG), TIMC-IMAG, Université de Grenoble Alpes, Grenoble, France

15. CRCSEP Côte d’Azur, CHU de Nice Pasteur 2, Nice, France/Université Nice Côte d’Azur UR2CA-URRIS, Nice, France

16. Service de Neurologie, CHU de Besançon, Besançon, France

17. Hôpital saint Philibert, Groupement des Hôpitaux de l’Institut Catholique de Lille, Faculté de médecine et de maïeutique de Lille, Lomme, France

18. Department of Neurology, Saint-Antoine Hospital, APHP-6, Paris, France/Sorbonne University, Paris, France

19. CRC-SEP, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France

20. Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France

21. Department of Neurology, Lille Catholic Hospitals, Lille Catholic University, Lille, France

22. Service de Neurologie, Centre Hospitalier de Lens, Lens, France

23. CRMBM, UMR 7339, CNRS, Aix-Marseille Université, Marseille, France/APHM Hôpital de la Timone, Marseille, France

24. Department of Neurology, Gonesse Hospital, Gonesse, France

25. Service de neurologie, Centre Hospitalier Régional Universitaire de Nancy – Hôpital Central, Nancy, France

26. Neuro-Dol, Inserm, Université Clermont Auvergne, Clermont-Ferrand, France/Department of neurology et CRC-SEP, CHU Clermont-Ferrand, Clermont-Ferrand, France

27. Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France/INSERM 1028 et CNRS UMR 5292, Centre de Recherche en Neurosciences de Lyon, Bron, France/Université Claude Bernard Lyon 1, Lyon, France

28. Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France/INSERM 1028 et CNRS UMR 5292, Centre de Recherche en Neurosciences de Lyon, Lyon, France/Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France

29. Service de Neurologie, CHU de Besançon, Besançon, France/Université Nice Côte d’Azur UR2CA-URRIS, Nice, France

Abstract

Objective: The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS). Background: MS typically affects young women in their childbearing years. Increasing evidence is available to inform questions raised by MS patients and health professionals about pregnancy issues. Methods: The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and university databases (January 1975 through June 2021). The RAND/UCLA appropriateness method was developed to synthesise the scientific literature and expert opinions on healthcare topics; it was used to reach a formal agreement. Fifty-six MS experts worked on the full-text review and initial wording of recommendations. A group of 62 multidisciplinary healthcare specialists validated the final proposal of summarised evidence. Results: A strong agreement was reached for all 104 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, locoregional analgesia or anaesthesia, prevention of postpartum relapses, breastfeeding, vaccinations, reproductive assistance, management of relapses and disease-modifying treatments. Conclusion: The 2022 recommendations of the French MS society should be helpful to harmonise counselling and treatment practice for pregnancy in persons with MS, allowing for better and individualised choices.

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/13524585221129472

Reference229 articles.

1. European Medicines Agency Committee for Medicinal Products for Human Use. Guideline on risk assessment of medicinal products on human reproduction and lactation: From data to labelling, https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-risk-assessment-medicinal-products-human-reproduction-lactation-data-labelling_en.pdf (2008, accessed 18 May 2022).

2. Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists

3. Haute Autorité de Santé. Development of good practice guidelines. ‘Formal consensus’ method, https://www.has-sante.fr/portail/upload/docs/application/pdf/2018-03/good_practice_guidelines_fc_method.pdf (2010, accessed 18 May 2022).

4. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy;Multiple Sclerosis Journal;2024-09-12

2. A Multicenter Multinational Study to Evaluate Different Aspects of the Relationship Between MS and Pregnancy;Multiple Sclerosis and Related Disorders;2024-09

3. Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy;Clinical and Translational Neuroscience;2024-08-01

4. Recommandations de la Société francophone de la sclérose en plaques « Vaccinations et sclérose en plaques » : mise à jour 2024;Pratique Neurologique - FMC;2024-06

5. Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies;Multiple Sclerosis and Related Disorders;2024-05